Prescription guides / Cost and access
Femring cost: 90-day ring and Medicare-program conditions
At a glance
A manufacturer-linked Medicare program advertises eligible patients may pay as little as $190 for one Femring ring lasting 90 days. It operates outside the Part D benefit with significant conditions. This is not a universal cash price or a Medicare-covered copay.

Price and savings evidence
Published figures below are a dated reference, not a pharmacy quote for you. Cash-price guides are secondary sources; manufacturer offers have separate eligibility rules. Confirm the exact product and final charge before filling. Prices and programs can change.
| Product or payment route | Published amount | What the amount means |
|---|---|---|
| Femring Medicare outside-benefit program | As little as $190 for one ring / 90-day supply | Conditional program for eligible Medicare Part D or Medicare Advantage drug-plan patients; not a Part D copay. Femring Medicare outside-benefit program terms. |
| Commercially insured route | Obtain a processed pharmacy quote | Manufacturer links a separate commercial program; no commercial dollar minimum is asserted here. Millicent: Femring savings routes. |
Read the Medicare conditions before enrolling
The program introduction discusses lack of coverage or opting out, while its enrollment certification requires that the Medicare plan does not cover the prescription. Confirm that requirement directly; do not assume anyone on Medicare qualifies. Femring Medicare outside-benefit program terms.
Participants agree not to seek reimbursement, not to count the purchase toward the deductible or true out-of-pocket costs, and to use the program rather than the Medicare benefit for Femring during the calendar year. This can affect the annual budget. Ask your plan or a Medicare counselor to compare the two routes before making that commitment. Femring Medicare outside-benefit program terms.
Identify the ring and full prescribed plan
Femring contains estradiol acetate and provides systemic estrogen delivery. Its labeled strengths release the equivalent of 0.05 or 0.10 mg estradiol per day over three months. It is not the local low-dose Estring product. Femring prescribing information.
Ask for one ring of the exact strength and the plan’s recorded days supplied. If a separate progestogen is prescribed, include that medicine too. The ring’s price does not establish a complete hormone-therapy cost. A visit for assistance with insertion or removal, if needed, may be billed separately.
Compare cash flow as well as a monthly equivalent
The advertised $190 divided across three 30-day periods is about $63.33 per period, but the purchase is for one ring. Do not compare that conditional Medicare-program amount with an unrestricted cash quote for a patch and claim a universal saving.
Questions about this decision
Will that purchase count toward my Part D limit?
The published program requires that it not be counted toward deductible or true out-of-pocket costs.
Is the offer for uninsured patients?
No. The cited program excludes uninsured and commercially insured patients; it is a separate Medicare-specific route.
Can I switch between this offer and Part D during the year?
The terms require program use for covered Femring purchases during the calendar year. Confirm the commitment before enrolling.
Is the ring alone the full regimen?
Not necessarily. Include any other medicine the clinician prescribes.
This guide helps prepare cost and coverage questions. It does not recommend starting, stopping or changing medicine. Your clinician and pharmacist should review the prescription and the full product label.
Organize your menopause budget
Use the main-site tools with your own prescription and care costs. Calculator estimates do not verify pharmacy prices or determine treatment suitability.
Explore menopause calculators →Related prescription decisions
Sources and limits
Selected source facts checked 2026-09-17. Medical facts use the linked labels; program details use the named official source. Cash-guide prices are secondary references, not verified local pharmacy quotes. No independent clinician review is claimed.